43 min listen
How Drug Price Controls End Up Hurting Patients
FromI AM BIO
ratings:
Length:
32 minutes
Released:
Sep 28, 2021
Format:
Podcast episode
Description
They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress—could have unintended consequences for the small biotechs that are the engine of the drug development ecosystem. And even worse, for the patients who need them most. Guests:Ahmed Mousa, Pieris Pharmaceuticals Daphne Zohar, PureTech HealthPeter Kolchinsky, RA CapitalMichele Oshman, BIOClare Thorpe, Library Services (AU)
Released:
Sep 28, 2021
Format:
Podcast episode
Titles in the series (100)
First Dose: One day before 16-year-old Izzy Thorpe-Wall takes her first dose of Vertex’s stunning Cystic Fibrosis breakthrough, Thorpe and her mother, Clare, open up about their emotional journey and one brave girl’s determination to stay healthy long enough to meet this day of her dreams. Hosted by Jim Greenwood. by I AM BIO